The current paradigm in genetic medicine relies on developing independent therapies for each separate mutation in the patient population.
Founded by pioneers in the CRISPR field from leading institutions for gene editing research, the company is developing a first-of-its-kind RNA writing platform capable of editing thousands of diverse mutations across patients with a single product.
Biology is the most sophisticated and specialized form of technology accessible to our species. We humbly study biological systems, learn from them, and put them back together in new ways to build technologies to improve health.
We blend complex science with biological design. Our work is made possible by approaching biology through an artisan lens, allowing us to explore new avenues, discover novel connections, and advance meaningful paradigms.
We believe in a future where life’s most complex diseases are treated at scale. Gene therapies should be safe, easy, precise, and affordable. We work backwards from impact, building out a new frontier of genetic medicine.
CTO and Co-Founder
CEO and Co-Founder
Senior Computational Biologist
VP of Development